4.2 Article

Topical application of celastrol alleviates atopic dermatitis symptoms mediated through the regulation of thymic stromal lymphopoietin and group 2 innate lymphoid cells

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/15287394.2021.1955785

Keywords

Skin; inflammation; immunity; environmental pollutants

Funding

  1. Catholic University of Korea
  2. National Research Foundation of Korea - Korean government (Ministry of Science, ICT and Future Planning) [NRF-2019R1A2C2085739, NRF-2020R1A4A2002894]

Ask authors/readers for more resources

The study showed that celastrol inhibited TSLP production by mouse keratinocyte cells and improved atopic dermatitis symptoms induced by house dust mite in mice. Celastrol reduced TSLP levels and Th2 cytokines, as well as decreased ILC2 population in atopic dermatitis skin lesions. These findings suggest that celastrol may alleviate atopic dermatitis symptoms by regulating TSLP levels and immune responses.
Atopic dermatitis is a chronic inflammatory skin disease, of which incidence is closely related to exposure to environmental pollutants and allergens. Thymic stromal lymphopoietin (TSLP) plays an important role in the early stages of atopic dermatitis development by inducing Th2 immune responses. In addition, TSLP regulates activation of group 2 innate lymphoid cells (ILC2), promoting the pathogenesis of atopic dermatitis. The aim of this study was to investigate whether celastrol alleviated atopic dermatitis symptoms by regulating TSLP expression and ILC2 stimulation. Celastrol suppressed TSLP production in mouse keratinocyte cells by inhibiting NF-kappa B activation. Topical application of celastrol significantly improved atopic dermatitis symptoms induced by house dust mite (HDM) in NC/Nga mice as determined by dermatitis score and histological assessment. Celastrol decreased the levels of TSLP in atopic dermatitis skin lesions of HDM-stimulated NC/Nga mice. Celastrol reduced levels of Th2 cytokines including IL-4, IL-5, and IL-13 in atopic dermatitis skin lesions of NC/Nga mice. Further, celastrol significantly reduced ILC2 population in atopic dermatitis skin lesions of NC/Nga mice. These results indicate that topical application of celastrol improved atopic dermatitis symptoms by lowering TSLP levels and concomitant immune responses. Data demonstrated that reduced TSLP levels and associated lower number of ILC2 cells alleviate atopic dermatitis symptoms induced by house dust mite.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available